Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Roberts receives approvable letter from FDA for Agrylin

Feb. 12, 1997

Potent gpIIb/IIIa antagonist synthesized using combinatorial techniques

Feb. 11, 1997

NIH funds development of antiplatelet agents from Cypress/PRP

Feb. 7, 1997

BASF discloses antithrombotic from ticks

Feb. 6, 1997

COR Therapeutics' cardiovascular drug candidate enters phase I trials

Feb. 5, 1997

DuPont Merck reports new fibrinogen antagonists

Jan. 31, 1997

New anticoagulant drug candidates from Berlex

Jan. 31, 1997

Serine protease inhibitors reported by Akzo Nobel

Jan. 31, 1997

Dutch investigators find method of improving t-PA therapy

Jan. 30, 1997

Pivotal Integrilin study fully enrolled

Jan. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...